Management of Atrial Fibrillation in COVID-19 Pandemic

被引：18

作者：

Hu, Yu-Feng ^{[1
,2
,3
]}

Cheng, Wen-Han ^{[1
]}

Hung, Yuan ^{[4
]}

Lin, Wen-Yu ^{[4
]}

Chao, Tze-Fan ^{[1
,2
,3
]}

Liao, Jo-Nan ^{[1
,2
,3
]}

Lin, Yenn-Jiang ^{[1
,2
,3
]}

Lin, Wei-Shiang ^{[4
]}

Chen, Yi-Jen ^{[5
]}

Chen, Shih-Ann ^{[1
,2
,3
]}

机构：

[1] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan

[2] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan

[3] Natl Yang Ming Univ, Cardiovasc Res Inst, Taipei, Taiwan

[4] Triserv Gen Hosp, Natl Def Med Ctr, Dept Med, Div Cardiol, Taipei, Taiwan

[5] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Cardiovasc Med, Taipei, Taiwan

来源：

CIRCULATION JOURNAL | 2020年 / 84卷 / 10期

关键词：

Ablation; Antiarrhythmic drugs; Atrial fibrillation; Oral anticoagulation; ANGIOTENSIN; INFLAMMATION; FLUTTER; MODULATION; AMIODARONE; ACTIVATION; STATEMENT; CONSENSUS; ABLATION; CATHETER;

D O I：

10.1253/circj.CJ-20-0566

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The health crisis due to coronavirus disease 2019 (COVID-19) has shocked the world, with more than 1 million infections and casualties. COVID-19 can present from mild illness to multi-organ involvement, but especially acute respiratory distress syndrome. Cardiac injury and arrhythmias, including atrial fibrillation (AF), are not uncommon in COVID-19. COVID-19 is highly contagious, and therapy against the virus remains premature and largely unknown, which makes the management of AF patients during the pandemic particularly challenging. We describe a possible pathophysiological link between COVID-19 and AF, and therapeutic considerations for AF patients during this pandemic.

引用

下载

页码：1679 / 1685

页数：7

共 50 条

[21] On the management of COVID-19 pandemic in Italy
Santeramo, Fabio Gaetano
Tappi, Marco
Lamonaca, Emilia
HEALTH POLICY, 2021, 125 (08) : 995 - 1001
[22] The Covid-19 pandemic and management controls
Ho, Hoa
Hofmann, Christian
Schwaiger, Nina
ACCOUNTING AND BUSINESS RESEARCH, 2023, 53 (05) : 583 - 607
[23] Increase in atrial fibrillation-related mortality in the United States during the COVID-19 pandemic
Zuin, Marco
Bilato, Claudio
HEART RHYTHM, 2023, 20 (02) : 163 - 164
[24] COVID-19 pandemic and trends in new diagnosis of atrial fibrillation: A nationwide analysis of claims data
Hernandez, Inmaculada
He, Meiqi
Guo, Jingchuan
Tadrous, Mina F.
Gabriel, Nico R.
Swabe, Gretchen
Gellad, Walid J.
Essien, Utibe W.
Saba, Samir
Benjamin, Emelia
Magnani, Jared
PLOS ONE, 2023, 18 (02):
[25] Impact of the COVID-19 Pandemic and Public Restrictions on Outcomes After Catheter Ablation of Atrial Fibrillation
Kim, Daehoon
Yu, Hee Tae
Kim, Tae-Hoon
Uhm, Jae-Sun
Joung, Boyoung
Lee, Moon-Hyoung
Pak, Hui-Nam
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
[26] Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic Reply
Bailon, Manuel Mendez
Gomez, Javier Aza na
Belmonte, Luis Perez
MEDICINA CLINICA, 2022, 159 (09): : E62 - E62
[27] Atrial fibrillation and COVID-19: an analysis of the ambulatory database
Sizova, Zhanna M.
Zakharova, Valeria L.
Shindryaeva, Natalya N.
Lapidus, Natalia I.
Melnik, Mariya V.
Shikh, Evgenia V.
Grebenshchikova, Ludmila Y.
Beloborodova, Alexandra V.
Polovikov, Ivan P.
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
[28] COVID-19 toes in a patient with atrial fibrillation on anticoagulation
Lolomari, Songo J.
Thayyil, Sheena
Berrington, Rachel
Kong, Marie-france
BRITISH JOURNAL OF DIABETES, 2022, 22 (01): : 49 - 51
[29] A COVID-19 Patient Presenting With Paroxysmal Atrial Fibrillation
Nouskas, Ioannis
Holeva, Vasiliki
Parlapani, Eleni
Nikopoulou, Vasiliki Aliki
Diakogiannis, Ioannis
CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
[30] Atrial fibrillation in COVID-19: A review of possible mechanisms
Stone, Elijah
Kiat, Hosen
McLachlan, Craig S.
FASEB JOURNAL, 2020, 34 (09): : 11347 - 11354

← 1 2 3 4 5 →